Get a quote today, we’ll call you back.

Get a Quote Today

Monkeypox in South Africa: Risks, Symptoms, and Prevention

Get a quote now

We’ll call you back

    View our Privacy Policy

    Monkeypox, a viral zoonosis with symptoms similar to those seen in the past in smallpox patients, has emerged as a significant global health concern. Originating from rodents and primates in Central and West Africa, Monkeypox has spread to various regions across the globe, leading to outbreaks that challenge public health systems. The disease presents with fever, rash, and swollen lymph nodes and can be severe in certain demographics, including immunocompromised individuals.

    With the recent uptick in cases in South Africa, staying informed cannot be overstated. Accurate, timely information is vital not only for preventing the spread of the virus but also for ensuring that those who may be infected receive the proper medical guidance promptly. Misinformation can lead to unnecessary panic or complacency, both of which can hinder effective disease control efforts.

    Understanding Monkeypox, recognising its symptoms, and knowing when and how to seek medical help are essential steps in managing this outbreak effectively. The South African public is encouraged to rely on trusted health sources for updates and to adhere to public health advisories, helping to protect themselves and their communities from further spread.

    What is Monkeypox?

    Monkeypox is a viral disease caused by the monkeypox virus, a member of the Orthopoxvirus genus in the family Poxviridae. The virus is closely related to the variola virus, which causes smallpox, and shares some clinical similarities. Monkeypox, however, typically presents with milder symptoms and has a lower fatality rate.

    Symptoms

    The symptoms of Monkeypox are similar to but milder than the symptoms of smallpox. After an incubation period that typically ranges from 7 to 14 days but can extend up to 21 days, the disease onset is usually marked by:

    • Fever
    • Intense headache
    • Swelling of the lymph nodes (lymphadenopathy), which is a distinctive feature of Monkeypox compared to other similar diseases, such as smallpox
    • Back pain
    • Muscle aches
    • Lack of energy

    A few days after the appearance of fever, the patient develops a rash, often beginning on the face and spreading to other parts of the body. The lesions progress from macules (flat lesions) to papules (slightly raised lesions), vesicles (fluid-filled blisters), pustules (pus-filled blisters), and finally to scabs that fall off. The number of lesions varies from a few to several thousand. In Africa, Monkeypox has been shown to cause death in as many as 1 in 10 persons who contract the disease, depending on the virus strain.

    Individuals are encouraged to monitor for these symptoms and consult health care providers promptly if Monkeypox is suspected. Early diagnosis and isolation can help manage the spread and treat the symptoms more effectively.

     

    Current Situation of Monkeypox in South Africa

    Recent Statistics from WHO

    • Total Cases: 20 confirmed cases
    • Fatalities: 3 deaths
    • Case Fatality Ratio (CFR): 15%

    Geographical Spread

    • Gauteng: 10 cases (1 death)
    • Western Cape: 1 case
    • KwaZulu-Natal: 9 cases (2 deaths)

    Summary of the Impact on Specific Groups:

    • Men who have sex with men (MSM): Disproportionately affected; significant number of cases within this community
    • Individuals with HIV: There is a high prevalence of cases among those with HIV, indicating a severe impact due to compromised immune systems
    • Other Vulnerable Populations: Includes individuals with other underlying health conditions like diabetes

    Transmission and Risk Factors of Monkeypox

    How Monkeypox Spreads

    • Human-to-Human Transmission:
      • Direct Contact: Close contact with the skin lesions, body fluids, or mucosal surfaces of an infected person.
      • Respiratory Droplets: Spread through large respiratory droplets during prolonged face-to-face contact.
      • Contaminated Objects: Using items such as bedding, towels, or clothing that have been contaminated with the virus from an infected person.
    • Animal to Human:
      • Direct Contact: Touching live or dead animals that are infected, particularly in regions where the disease is more common.
      • Consumption: Eating meat of infected animals that is not properly cooked.

    High-Risk Groups

    • Men Who Have Sex with Men (MSM): This group has been identified as particularly vulnerable in the current outbreak due to close physical contact, which can facilitate transmission.
    • People with HIV: Especially those with unmanaged or newly diagnosed HIV infections who have more severe immunosuppression.
    • Healthcare Workers: At risk due to exposure to infected patients without adequate personal protective equipment (PPE).

    Additional Risk Factors

    • Close Physical Contact: Individuals who live in or visit areas with known cases and have close physical contact with someone who has Monkeypox are at increased risk.
    • Attendance at Certain Venues: Visiting places where close contact occurs, such as clubs or parties where Monkeypox has been reported, increases the risk of transmission.

     

    Understanding these transmission modes and risk factors is important for preventing the spread of Monkeypox and protecting those who are most at risk.

    Prevention Strategies for Monkeypox

    Personal Precautions

    Taking personal steps to prevent Monkeypox is crucial, especially in regions experiencing outbreaks.

    Here are key measures individuals can adopt:

    • Hygiene Practices:
      • Hand Hygiene: Wash your hands regularly with soap and water for at least 20 seconds, especially after contact with sick individuals or touching potentially contaminated surfaces.
      • Sanitisers: Use alcohol-based hand sanitisers when soap and water are not available.
    • Avoid Contact:
      • Infected Individuals: Avoid close, skin-to-skin contact with people who have a rash that resembles Monkeypox.
      • Contaminated Materials: Do not share eating utensils or bedding with someone suspected of having Monkeypox.
    • Protective Measures:
      • Masks: Wear a mask in high-risk settings or if you are caring for someone infected with Monkeypox.
      • Gloves: Use gloves when caring for or coming into direct contact with an infected person.

    These health measures are vital to effectively preventing and controlling the spread of Monkeypox, ensuring that communities stay informed and protected.

    Treatment Options for Monkeypox

    Current Treatments

    While there is no cure specifically for Monkeypox, there are treatments available that can help manage the disease and alleviate symptoms:

    • Antiviral Medications:
      • Tecovirimat (TPOXX): Currently the most prominent antiviral used for treating Monkeypox. It is designed to target orthopoxviruses, the family to which Monkeypox belongs. Tecovirimat has been made available through emergency use authorisation in some regions and has shown efficacy in reducing symptoms and potentially shortening the course of the disease.

    Supportive Care

    Managing symptoms and providing supportive care are critical components of treating Monkeypox, especially since specific treatments can be limited:

    • Skin Care: Regularly cleaning monkeypox lesions with sterilised water or antiseptic solutions to prevent secondary infections.
    • Pain Management: Over-the-counter pain relievers such as acetaminophen or ibuprofen to alleviate pain and reduce fever.
    • Hydration and Nutrition: Ensuring adequate fluid intake and a nutritious diet to support overall health and recovery.
    • Rest: Encouraging ample rest to help the body fight off the infection.

    Monitoring and Adjustments

    • Regular Monitoring: Patients undergoing treatment should be monitored regularly by healthcare professionals to adjust care plans as needed and to manage any complications that may arise.
    • Follow-up Care: Follow-up visits are crucial to assess recovery progress and manage any long-term effects of the infection.

     

    The combination of antiviral treatment and comprehensive supportive care is vital to managing Monkeypox effectively, helping patients recover more comfortably and potentially reducing the duration of the illness.

    Stay Informed and Seek Help

    Follow Health Guidelines

    To protect yourself and your community, it’s essential to adhere to health guidelines issued by local and international health authorities. Taking proactive steps can significantly reduce the risk of contracting and spreading Monkeypox:

    • Consult Healthcare Professionals: If you or someone you know exhibits symptoms of Monkeypox, such as fever, rash, or lymph node swelling, consult a healthcare provider promptly. Early medical intervention can lead to better health outcomes.

    Additional Resources

    • Educational Materials:
      • World Health Organization (WHO) Monkeypox Page: Offers comprehensive details about the disease, its prevention, and global updates. Visit WHO Monkeypox Information.
      • Centers for Disease Control and Prevention (CDC): Provides resources on monkeypox symptoms, transmission, and prevention. Access the CDC’s resources at CDC Monkeypox Overview.

     

    We can disrupt the local transmission by supporting those diagnosed with this disease to take their treatment to prevent infecting others. We can prevent avoidable deaths by cooperating with health officials when they conduct contact tracing and case finding.One death is too many, especially from a preventable and manageable disease like mpox. – Minister Joe Phaahla, South Africa Department of Health

     

    By staying informed and vigilant, adhering to recommended health practices, and seeking medical advice when necessary, we can collectively manage and overcome the spread of Monkeypox. Remember, your actions can make a difference in safeguarding your health and the health of those around you.

    Your journey to quality healthcare starts here.

    Health Insurance

    Health4Me Bronze

    Health4Me Silver

    Health4Me Gold

    Gap Cover

    Gap Core

    Gap Max

    About

    About Bloom

    Frequently Asked Questions

    Blog

    Contact Us

    Momentum Health4Me is not a medical scheme product, and is not a substitute for medical scheme membership. The information provided on this website does not constitute advice in terms of the Financial Advisory and Intermediary Services Act. Momentum is a division of Momentum Metropolitan Life Limited, an authorised financial services provider (FSP 6406) and a wholly owned subsidiary of Momentum Metropolitan Holdings Limited.

    Bloom Gap Cover is not a medical Scheme. Products that are offered are not the same as that of a medical scheme.

    © Bloom Financial Services 2023. Bloom Financial Services (Pty) Ltd is an authorised financial services provider (FSP 50140). Bloom Gap is underwritten by Infiniti Insurance Limited a licensed non-life insurer and an authorised financial services provider (FSP No.35914)

    Privacy Policy